Investing.com - Collplant ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Collplant ADR announced earnings per share of $0.16 on revenue of $15.64M. Analysts polled by Investing.com anticipated EPS of $-0.26 on revenue of $338K.
Collplant ADR shares are down 24.33% from the beginning of the year, still down 47.30% from its 52 week high of $23.49 set on June 23, 2021. They are under-performing the Nasdaq which is down 11.01% from the start of the year.
Collplant ADR follows other major Healthcare sector earnings this month
Collplant ADR's report follows an earnings missed by Merck ADR on March 3, who reported EPS of $0.4558 on revenue of $5.77B, compared to forecasts EPS of $0.4818 on revenue of $5.88B.
Moderna had beat expectations on February 24 with fourth quarter EPS of $11.29 on revenue of $7.21B, compared to forecast for EPS of $9.96 on revenue of $6.8B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar